New analysis presented by the company, together with an improved discount to the price of vamorolone, mean that NICE can now ...

Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...

Public involvement is important, expected and possible in all types of health and social care research.

Obesity is one of the greatest public health issues facing the NHS and weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other ...

There is a simple discount patient access scheme for bevacizumab gamma. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

Our guests are Marie Anne Ledingham, a Consultant Clinical Adviser at NICE and an NHS obstetrician and gynecologist. And Professor Martha Hickey, consultant in Gynaecology at the Royal Women’s ...

Following on from advice received from the company, NICE has decided to suspend this appraisal from its work programme whilst the company confirm their regulatory filing plans ...

There is a simple discount patient access scheme for crizotinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...